Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 31% ± 17% | |
lung | 11 studies | 21% ± 4% | |
peripheral blood | 7 studies | 23% ± 8% | |
eye | 6 studies | 25% ± 13% | |
kidney | 5 studies | 19% ± 2% | |
intestine | 5 studies | 21% ± 7% | |
bone marrow | 4 studies | 20% ± 4% | |
liver | 4 studies | 31% ± 14% | |
adipose | 4 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 4776.89 | 578 / 578 | 100% | 41.59 | 1155 / 1155 |
prostate | 100% | 5303.33 | 245 / 245 | 100% | 38.50 | 502 / 502 |
esophagus | 100% | 4334.46 | 1444 / 1445 | 100% | 48.86 | 183 / 183 |
bladder | 100% | 4703.24 | 21 / 21 | 100% | 40.69 | 503 / 504 |
brain | 100% | 3286.60 | 2639 / 2642 | 100% | 31.96 | 704 / 705 |
breast | 100% | 5185.56 | 459 / 459 | 100% | 55.07 | 1115 / 1118 |
thymus | 100% | 5711.07 | 653 / 653 | 100% | 37.04 | 603 / 605 |
intestine | 100% | 4705.10 | 966 / 966 | 100% | 40.79 | 525 / 527 |
pancreas | 100% | 2697.24 | 328 / 328 | 99% | 32.76 | 177 / 178 |
uterus | 100% | 5103.18 | 170 / 170 | 99% | 44.87 | 456 / 459 |
ovary | 100% | 5542.71 | 180 / 180 | 99% | 26.67 | 427 / 430 |
stomach | 100% | 3563.91 | 359 / 359 | 99% | 40.88 | 282 / 286 |
adrenal gland | 100% | 5253.29 | 258 / 258 | 98% | 23.20 | 225 / 230 |
kidney | 100% | 3951.36 | 89 / 89 | 97% | 26.56 | 877 / 901 |
liver | 100% | 2369.83 | 226 / 226 | 94% | 20.25 | 380 / 406 |
skin | 100% | 5763.27 | 1809 / 1809 | 93% | 31.64 | 439 / 472 |
adipose | 100% | 4888.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 41.71 | 29 / 29 |
muscle | 100% | 3679.07 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5566.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 39.82 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.07 | 1 / 1 |
blood vessel | 100% | 4206.51 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 2585.40 | 846 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 57% | 12.76 | 46 / 80 |
peripheral blood | 57% | 2240.94 | 533 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0006915 | Biological process | apoptotic process |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005641 | Cellular component | nuclear envelope lumen |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0003723 | Molecular function | RNA binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0030374 | Molecular function | nuclear receptor coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CCAR1 |
Protein name | Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1) (Death inducer with SAP domain) Cell division cycle and apoptosis regulator 1 |
Synonyms | DIS CARP1 |
Description | FUNCTION: Associates with components of the Mediator and p160 coactivator complexes that play a role as intermediaries transducing regulatory signals from upstream transcriptional activator proteins to basal transcription machinery at the core promoter. Recruited to endogenous nuclear receptor target genes in response to the appropriate hormone. Also functions as a p53 coactivator. May thus play an important role in transcriptional regulation (By similarity). May be involved in apoptosis signaling in the presence of the reinoid CD437. Apoptosis induction involves sequestration of 14-3-3 protein(s) and mediated altered expression of multiple cell cycle regulatory genes including MYC, CCNB1 and CDKN1A. Plays a role in cell cycle progression and/or cell proliferation . In association with CALCOCO1 enhances GATA1- and MED1-mediated transcriptional activation from the gamma-globin promoter during erythroid differentiation of K562 erythroleukemia cells . Can act as a both a coactivator and corepressor of AR-mediated transcription. Contributes to chromatin looping and AR transcription complex assembly by stabilizing AR-GATA2 association on chromatin and facilitating MED1 and RNA polymerase II recruitment to AR-binding sites. May play an important role in the growth and tumorigenesis of prostate cancer cells . . |
Accessions | ENST00000540210.5 F5H3E1 H0YFJ7 F5H3I8 ENST00000538031.5 ENST00000265872.11 [Q8IX12-1] ENST00000543225.5 A0A0C4DGG8 F5H7M9 ENST00000630771.2 H0YFT7 ENST00000543706.1 F5H1H2 ENST00000543229.5 ENST00000536391.5 Q8IX12 F5H2E6 F5H1L3 ENST00000536012.5 ENST00000541012.5 F5H808 ENST00000479143.2 ENST00000539539.5 ENST00000543719.5 [Q8IX12-2] ENST00000494903.2 |